At 17.1% CAGR, the South & Central America Needle-Free Injection Systems Market is projected to be worth US$ 24.84 million by 2028, says Business Market Insights

According to Business Market Insights’ research, the South & Central America needle-free injection systems market was valued at US$ 9.63 million in 2022 and is expected to reach US$ 24.84 million by 2028, registering a CAGR of 17.1% from 2022 to 2028. Advantages of using self-injection devices and rising demand for vaccines and biosimilars are the critical factors attributed to the South & Central America needle-free injection systems market expansion.

The development cost of needle free injectors is high as these needles have higher infrastructural and labor costs and are complex to manufacture compared to conventional injections. Sterilizable needles and conventional injections are cheaper as they cost approximately US$ 5-15 for 1,000 injections; however, needle free injections are likely to be more expensive. For starter kits for needle free injections, the patients must pay ~US$ 165 for the standard product, and it goes higher with the advanced products. For instance, the cost of AdvantaJet and Medi-Jector is US$ 260 for 30 injections and US$ 300, respectively. The cost of these products is higher because the manufacturers are required to spend more on the production standard and quality control of the devices compared to conventional injection systems. Due to such excessive costs, affordability becomes a major issue for needle free injection devices.

Further, meeting all the standards and regulatory requirements makes the manufacturing process of needle free injection systems more expensive than traditional injections. Regulatory bodies have different mandates in different regions for approval of a product or the formulation of combination products. Thus, a manufacturer trying to market a needle free injection system must provide additional device safety data and conduct clinical trials to meet regulatory requirements. Thus, needle free injection systems require higher development costs and more time to enter the market than conventional drug delivery systems, which is restraining the growth of the South & Central America needle-free injection systems market.

Based on product, the South & Central America needle-free injection systems market is sub segmented into fillable needle-free injectors and prefilled needle-free injectors. The fillable needle-free injectors segment held 63.8% of the South & Central America needle-free injection systems market share in 2022, amassing US$ 6.15 million. It is projected to garner US$ 15.63 million by 2028 to expand at 16.8% CAGR during 2022–2028.

Based on technology, the South & Central America needle-free injection systems market is segmented into jet-based needle-free injectors, spring-based needle-free injectors, microarray patch injectors, and others. The jet-based needle-free injectors segment former held 32.8% of the South & Central America needle-free injection systems market share in 2022, amassing US$ 3.16 million. It is projected to garner US$ 8.43 million by 2028 to expand at 17.7% CAGR during 2022–2028.

Based on type, the South & Central America needle-free injection systems market is segmented into market is segmented into liquid-based needle-free injectors, projectile-based needle-free injectors, and powder-based needle-free injectors. The liquid-based needle-free injectors segment held 71.0% market share in 2022, amassing US$ 6.83 million. It is projected to garner US$ 17.45 million by 2028 to expand at 16.9% CAGR during 2022–2028.

Based on durability, the South & Central America needle-free injection systems market is bifurcated into disposable and reusable. With 59.8% share of the domain, the reusable segment dominated the market in 2022. It accrued US$ 5.76 million in 2022 and is estimated to generate US$ 14.62 million by 2028 to grow at a CAGR of 16.8% over the forecast period.

Based on site of delivery, the South & Central America needle-free injection systems market is segmented into subcutaneous injectors, intramuscular injectors, and intradermal injectors. The subcutaneous injectors segment held 49.4% market share in 2022, amassing US$ 4.75 million. It is projected to garner US$ 12.55 million by 2028 to expand at 17.6% CAGR during 2022–2028.

Based on application, the South & Central America needle-free injection systems market is segmented into vaccine delivery, insulin delivery, oncology, pain management, dermatology, and others. The vaccine delivery segment held 32.4% market share in 2022, amassing US$ 3.12 million. It is projected to garner US$ 8.35 million by 2028 to expand at 17.8% CAGR during 2022–2028.

Based on end user, the South & Central America needle-free injection systems market is segmented into hospitals, home care settings, research laboratories, pharmaceutical and biotechnology companies, and others. The hospitals segment held 33.2% market share in 2022, amassing US$ 3.20 million. It is projected to garner US$ 8.47 million by 2028 to expand at 17.6% CAGR during 2022–2028.

Based on country, the South & Central America needle-free injection systems market is segmented into Brazil, Argentina, and the Rest of South & Central America. Our regional analysis states that Brazil captured 68.6% market share in 2022. It was assessed at US$ 6.61 million in 2022 and is likely to hit US$ 17.29 million by 2028, exhibiting a CAGR of 17.4% during the forecast period.

Key players dominating the South & Central America needle-free injection systems market are Crossject; Ferring B.V.; Medical International Technologies (MIT Canada) Inc.; NuGen Medical Devices; and Zealand Pharma A/S, among others.

• In June 2022, NuGen Medical Devices Inc., a leader in needle-free drug delivery, has announced that it will be launching a needle-free injection device specifically designed for domesticated household pets. The PetJet will allow pet owners and veterinarians to safely and quickly inject various types of medication without the fear of hurting their pets with a traditional hypodermic needle.

Contact Us
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email Id: sales@businessmarketinsights.com